Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab

Arnon P. Kater; Yanwen Jiang; Brenda Chyla; John F. Seymour

doi:https://doi.org/10.3324/haematol.2020.253849

Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab

Arnon P. Kater, Yanwen Jiang, Brenda Chyla, John F. Seymour

Research output: Contribution to journal › Comment/Letter to the editor › Academic

6 Citations (Scopus)

Original language	English
Pages (from-to)	e382-e383
Journal	Haematologica
Volume	105
Issue number	7
DOIs	https://doi.org/10.3324/haematol.2020.253849
Publication status	Published - 1 Jul 2020

Access to Document

https://doi.org/10.3324/haematol.2020.253849

Cite this

@article{f2103fb5c8464e0bbd7a40989a9deb85,

title = "Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab",

author = "Kater, {Arnon P.} and Yanwen Jiang and Brenda Chyla and Seymour, {John F.}",

year = "2020",

month = jul,

day = "1",

doi = "https://doi.org/10.3324/haematol.2020.253849",

language = "English",

volume = "105",

pages = "e382--e383",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "7",

}

TY - JOUR

T1 - Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab

AU - Kater, Arnon P.

AU - Jiang, Yanwen

AU - Chyla, Brenda

AU - Seymour, John F.

PY - 2020/7/1

Y1 - 2020/7/1

UR - http://www.scopus.com/inward/record.url?scp=85087612284&partnerID=8YFLogxK

U2 - https://doi.org/10.3324/haematol.2020.253849

DO - https://doi.org/10.3324/haematol.2020.253849

M3 - Comment/Letter to the editor

C2 - 32611578

SN - 0390-6078

VL - 105

SP - e382-e383

JO - Haematologica

JF - Haematologica

IS - 7

ER -

Response in patients with BIRC3-mutated relapsed/refractory chronic lymphocytic leukemia treated with fixed-duration venetoclax and rituximab

Access to Document

Other files and links

Cite this